Pan-Vilon contains Vilon—the shortest known bioactive peptide (Lys-Glu)—which targets thymic tissue to support immune-cell maturation. Despite its minimal size of just two amino acids, Vilon demonstrates remarkable epigenetic activity on T-lymphocyte gene expression.
Vilon (Lys-Glu) is a di-peptide discovered by Prof. Khavinson's team as the minimum effective immunomodulatory sequence. Pan-Vilon delivers this ultra-short peptide in a bioavailable format that supports thymic function, enhances T-cell proliferation, and modulates immune response balance. Its tiny molecular weight ensures rapid absorption and cellular uptake. Ideal for immune maintenance in ageing adults.